ZJKC Launches Home-Use rTMS Apparatus: Advancing Non-Invasive Neurological Therapy

ZJKC introduces its Repetitive Transcranial Magnetic Stimulation (rTMS) Apparatus, a breakthrough device that brings non-invasive brain stimulation to homes, supporting treatment for depression, stroke recovery, and neurological disorders with personalized, easy-to-use technology. End Quote

(1888PressRelease) July 29, 2025 - ZJKC, a leader in innovative medical devices, is proud to announce the launch of its Repetitive Transcranial Magnetic Stimulation (rTMS) Apparatus—a cutting-edge solution designed to transform neurological and psychiatric care through non-invasive technology. This portable device merges clinical-grade efficacy with home accessibility, empowering patients to take control of their recovery journey.

The rTMS Apparatus operates on a scientifically validated principle: magnetic pulses delivered via a scalp-placed coil target specific brain regions, inducing small electric currents that modulate neuronal activity. High-frequency stimulation (≥10 Hz) enhances cortical excitability, while low-frequency (1 Hz) reduces overactivity, promoting neuroplasticity and lasting functional improvements. This approach avoids surgery, medications, or invasive procedures, prioritizing patient comfort.

Versatile in application, the device addresses a range of conditions:

Mental Health: Proven to alleviate depression, anxiety, and insomnia by regulating mood-related neural pathways.
Neurological Recovery: Aids post-stroke rehabilitation, supports management of Alzheimer’s and Parkinson’s, and enhances motor function.
Chronic Conditions: Helps manage chronic pain and improves sleep disorders by balancing brain activity.

“Patients and clinicians alike need solutions that are effective, accessible, and adaptable,” said [Spokesperson Name], ZJKC’s Product Development Lead. “Our rTMS Apparatus meets this need—combining precision with convenience to bridge clinical care and daily life.”

Key features include personalized therapy options (multiple coil heads and adjustable frequencies), pre-programmed modes for clinician efficiency, and a compact design enabling home use. This accessibility ensures consistent treatment, a critical factor in neuroplasticity and long-term recovery.

Clinicians benefit from intuitive controls that reduce setup time, while patients appreciate the non-invasive, adjustable settings that enhance comfort and compliance. By enabling at-home therapy, ZJKC eliminates barriers like clinic visits, making consistent care feasible for more individuals.

The ZJKC rTMS Apparatus underscores the company’s commitment to patient-centered innovation. As neurological care evolves, this device stands out as a versatile tool, offering hope for those with treatment-resistant conditions.

###

space

Other Related Press Releases